Concepedia

Lore Mariën

LM

Statistics

Publications

4

Citations

231

H-Index

4

Active since

2015

Affiliations

KU Leuven(Current)

Ablynx (Belgium)

Lore Mariën is an author at KU Leuven specializing in oncology, medicine, and checkpoint inhibitor therapy.

ORCID

Publications per year

2015–2020

4

Publications

4

Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer

Grégoire de Streel, Charlotte Bertrand, Nicolas Chalon et al. · Nature Communications · 2020 · 139 citations · Full text

, , +17

Tumor-environment biomimetics delay peritoneal metastasis formation by deceiving and redirecting disseminated cancer cells

Elly De Vlieghere, Félix Gremonprez, Laurine Verset et al. · Biomaterials · 2015 · 45 citations

, , +16

Ca2+ homeostasis in the budding yeast Saccharomyces cerevisiae: Impact of ER/Golgi Ca2+ storage

Petra D’hooge, Catherina Coun, Vincent Van Eyck et al. · Cell Calcium · 2015 · 26 citations · Full text

, , +16

A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3

Janna Bednenko, Rian Harriman, Lore Mariën et al. · mAbs · 2018 · 21 citations · Full text

, , +16

1–4 of 4